The U.S. Food and Drug Administration and the pharmaceutical company Novo Nordisk are urging consumers to be on the lookout ...

US stocks plunged following Trump's comments, with the S&P 500 ( ^GSPC) closing Monday's session down 2.4%, the tech-focused Nasdaq ( ^IXIC) sliding 2.6% and the Dow Jones Industrial Average ( ^DJI) ...

Shares in electric vehicle (EV) company Tesla (TSLA ... Another European pharmaceutical giant in focus on Tuesday was Novo Nordisk (NOVO-B.CO), with its shares down 7.4% in morning trading.

The scale of President Donald Trump’s tariffs has exceeded even the most bearish forecasts — and could impact these five ...

Stock markets are a bit lost as we move towards Thursday. Concerns that earnings data is weak for Q1 in Europe and the US, a delay in US and China trade negotiations, and delays to a Ukraine and ...

Asian markets climbed on Friday and closed higher upon hopes that there may be an easing of the trade war between China and ...

Novo Nordisk now has an Ozempic pill. Citing a Novo spokesperson, pharmaceuticals news site BioPharmaDive reported yesterday ...

But recent weak U.S. prescription data is leading some investors and analysts to question whether that stellar run, which ...

Patients flocked to those Ozempic, Wegovy copycats when the branded drugs were in short supply, or if they didn’t have ...

Novo Nordisk (NYSE: NVO), the Danish drugmaker that's been riding high ever since it began putting out Ozempic and Wegovy GLP-1 injectables for treatment of diabetes and weight loss, got another ...